Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) had Free Cash Flow of $-79.82M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-50.34M |
|
-- |
|
-- |
|
$54.65M |
|
$-54.65M |
|
$5.09M |
|
$-49.56M |
|
$-49.56M |
|
$-50.34M |
|
$-50.34M |
|
$-50.34M |
|
$-50.34M |
|
$-54.65M |
|
$-52.05M |
|
133.68M |
|
133.68M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$300.36M |
|
$0.73M |
|
$191.76M |
|
$492.13M |
|
$29.69M |
|
$109.55M |
|
$117.51M |
|
$147.21M |
|
$344.92M |
|
$344.92M |
|
$344.92M |
|
133.91M |
|
| Cash Flow Statement Financials | |
$-79.70M |
|
$-262.34M |
|
$4.69M |
|
$383.22M |
|
$44.24M |
|
$-338.98M |
|
$15.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.12 |
|
-- |
|
-- |
|
0.24 |
|
0.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-79.82M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.60% |
|
-14.60% |
|
-10.23% |
|
-11.08% |
|
$2.58 |
|
$-0.60 |
|
$-0.60 |
|